Using Goal Setting in Parkinson's Disease Trials
Author Information
Author(s): Emma Tenison, Katherine Lloyd, Yoav Ben-Shlomo, Emily J. Henderson
Primary Institution: University of Bristol
Hypothesis
Can a goal-oriented outcome measure effectively evaluate a multicomponent intervention for people with parkinsonism?
Conclusion
A goal-oriented outcome measure can be effectively used in trials for parkinsonism, providing meaningful insights into patient experiences.
Supporting Evidence
- Goal-oriented outcomes can capture the complex experiences of patients with Parkinson's disease.
- The Bangor Goal-setting Interview allows for personalized goal setting and tracking.
- Using goal-oriented measures can improve the relevance of outcomes in clinical trials.
Takeaway
This study shows that setting personal goals can help people with Parkinson's disease feel better and track their progress in a way that matters to them.
Methodology
The study adapted the Bangor Goal-setting Interview for use in a randomized controlled trial evaluating a multicomponent care model for Parkinson's disease.
Potential Biases
Potential bias from caregiver input in goal setting, especially for participants with cognitive impairment.
Limitations
The lack of a defined minimal clinically important difference for the Bangor Goal-setting Interview limits its utility.
Participant Demographics
Participants included individuals with parkinsonism, frailty, multimorbidity, and cognitive impairment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website